Mithila Hag Farin and her mother. Mithila lives in Bangladesh and has type 1 diabetes
See how partnerships are improving health systems and lives in Tanzania, and worldwide
The Novo Nordisk Haemophilia Foundation at work in Malawi
Americans using our $25 low-cost insulin programme.
people with diabetes treated with our human insulin at a maximum of USD 4 per 10ml vial.
people using our diabetes care products globally.
people with haemophilia and family members benefitting from educational activities led by the Novo Nordisk Haemophilia Foundation.
The way our medicines are priced and reimbursed varies a lot between countries. We believe new outcomes-based pricing models will contribute to better evaluation of the true value of our medicines. Our commitment is to drive initiatives aimed at finding innovative, outcomes-based pricing models in close collaboration with other key stakeholders.